![Michael Bart Sheffery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bart Sheffery
Direktor/Vorstandsmitglied bei
Eximias Pharmaceutical Corp.
Profil
Dr. Michael B. Sheffery is Partner Emeritus at OrbiMed Advisors LLC.
He joined the firm in 1989.
In addition to that, he is General Partner at OrbiMed Advisors Private Equity.
He is on the Board of Directors at Biosynexus, Inc., Eximias Pharmaceutical Corp., CoGenesys, Inc., Affimed Therapeutics AG, Pieris AG, and arGEN-X BV.
Dr. Sheffery was previously employed as Independent Director by Athersys, Inc., Independent Director by Supernus Pharmaceuticals, Inc., and Head-Laboratory by New York Cancer Hospital.
He also served on the board at BTHC VI, Inc., Memory Pharmaceuticals Corp., and NeoGenesis Pharmaceuticals, Inc.
Dr. Sheffery received both his PhD in Molecular Biology and his BA in Biology from Princeton University.
He joined Mehta and Isaly in 1996 as a Senior Analyst covering the biotechnology industry.
Aktive Positionen von Michael Bart Sheffery
| Unternehmen | Position | Beginn |
|---|---|---|
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer disorders | Direktor/Vorstandsmitglied | - |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Direktor/Vorstandsmitglied | - |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Michael Bart Sheffery
| Unternehmen | Position | Ende |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 29.10.2012 |
| ATHERSYS, INC. | Direktor/Vorstandsmitglied | 09.09.2010 |
BTHC VI, Inc.
 BTHC VI, Inc. Financial ConglomeratesFinance Development stage company | Direktor/Vorstandsmitglied | 06.09.2007 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Corporate Officer/Principal | 14.01.2003 |
| AFFIMED N.V. | Direktor/Vorstandsmitglied | - |
Ausbildung von Michael Bart Sheffery
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Health Technology |
Eximias Pharmaceutical Corp.
Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer disorders | Health Technology |
BTHC VI, Inc.
BTHC VI, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Pieris AG
 Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Health Services |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Health Technology |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
